Severe cryptogenic bronchiolitis: Case report
- PMID: 37663528
- PMCID: PMC10470279
- DOI: 10.1016/j.rmcr.2023.101910
Severe cryptogenic bronchiolitis: Case report
Abstract
Bronchiolitis obliterans (BO) is a progressive fibrotic process that predominantly affects the small airways and is identified as constrictive bronchiolitis by pathologists. It is commonly associated with allogeneic hematopoietic stem cell transplant (HSCT), lung transplant, exposure to inhaled toxins, post-infectious processes, autoimmune diseases, and sometimes, no known cause. In the latter case, it is referred to as cryptogenic bronchiolitis obliterans. A 52-year-old Hispanic man with a medical history of hypertension, diabetes mellitus, and coronary artery disease was referred to the pulmonary department due to experiencing dyspnea on exertion, intermittent dry cough, and progressive limitation of activities of daily living. Spirometry revealed severe obstructive changes, and chest high-resolution computed tomography showed ground-glass opacities with nodular infiltrates in the upper lobes, leading to a presumptive diagnosis of hypersensitivity pneumonitis. The patient underwent a lung surgical biopsy of the right upper and lower lobes, which revealed extensive constrictive bronchiolitis. Due to the patient's worsening general condition, bilateral lung transplantation succeeded without any further complications. Following the transplantation, the patient showed good recovery and functional improvement. Bronchiolitis obliterans, or constrictive bronchiolitis, has a variable natural history. It is associated with a higher risk of mortality in allogenic HSCT. When BO is secondary to inhalation of toxic gases, it is usually nonprogressive and limited to toxin exposure. Autoimmune diseases or cryptogenic bronchiolitis are rare and have a heterogeneous clinical course. To make a proper diagnosis, clinical history, radiologic and histologic findings must be considered.
Keywords: Bronchiolitis; Constrictive bronchiolitis; Lung transplant; Obstructive pulmonary disease; Small airway.
© 2023 The Authors.
Conflict of interest statement
We have no conflicts of interest to disclose. This manuscript has not been published and is not under consideration for publication elsewhere. Additionally, all of the authors have approved the contents of this paper and have agreed to the journal's submission policies.
Figures






References
-
- Barker A.F., Bergeron A., Rom W.N., Hertz M.I. Obliterative bronchiolitis. N. Engl. J. Med. 2014 May 8;370(19):1820–1828. - PubMed
-
- Swaminathan A.C., Carney J.M., Tailor T.D., Palmer S.M. Overview and challenges of bronchiolar disorders. Ann Am Thorac Soc. 2020 Mar;17(3):253–263. - PubMed
-
- Krishna R., Anjum F., Oliver T.I. StatPearls. StatPearls Publishing; Treasure Island (FL): 2022. Bronchiolitis obliterans.http://www.ncbi.nlm.nih.gov/books/NBK441865/ [Internet] [cited 2023 Mar 2]. Available from: - PubMed
Publication types
LinkOut - more resources
Full Text Sources